Curis (CRIS)

• Market cap: $16.2M
• 1 day: 10.62%
• 5 days: 9.65%
• 1 month: -19.87%
• 3 months: -25.15%
• 6 months: -38.73%
• Year to date: -70.52%
• 1 year: -68.98%
• 5 years: -95.66%
• 10 years: -99.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 33